Table 1

Clinical characteristics before discharge in patients with low and high Ed/Ea

Ed/EaP value (low vs high)
≤0.144 (n=376)>0.144 (n=176)
Age, years80±983±90.002
Male sex, n (%)195 (52)60 (34)<0.001
Systolic blood pressure, mm Hg122±17116±16<0.001
Diastolic blood pressure, mm Hg67±1163±11<0.001
Heart rate, bpm72±1371±140.649
Atrial fibrillation, n (%)142 (38)58 (33)0.273
Chronic obstructive pulmonary disease, n (%)26 (7)9 (5)0.534
Coronary artery disease, n (%)72 (19)46 (26)0.062
Diabetes mellitus, n (%)130 (35)64 (36)0.681
Dyslipidaemia, n (%)156 (41)78 (44)0.531
Hypertension, n (%)320 (85)157 (89)0.190
Laboratory data
 Albumin, g/dL3.4±0.53.4±0.50.607
 eGFR, mL/min/1.73 m244.3±18.939.2±18.70.003
 Haemoglobin, g/dL11.5±2.111.1±1.90.061
 N-terminal pro-brain natriuretic peptide, pg/mL2202±44063669±89630.014
Echocardiographic data
 LAD, mm43±846±8<0.001
 LAVI, mL/m252±2460±26<0.001
 LVEDVI, mL/m254±2154±200.989
 LVESVI, mL/m222±1121±100.405
 SVI, mL/m232±1233±130.515
 SV/LAV0.74±0.410.65±0.350.010
 LVEF, %60±761±80.311
 TAPSE, mm17.7±4.417.4±4.60.481
 E/e'10.9±2.919.6±4.8<0.001
Medications
 Beta-blockers, n (%)207 (55)96 (55)0.911
 Calcium channel blockers, n (%)197 (52)93 (53)0.921
 Diuretics, n (%)309 (82)152 (86)0.217
 RAAS inhibitors, n (%)272 (72)136 (77)0.218
 Statins, n (%)122 (32)65 (37)0.299
  • Values are presented as means±SD or numbers (%).

  • Ea, arterial elastance; Ed, diastolic elastance; eGFR, estimated glomerular filtration rate; LAD, left atrial diameter; LAV, left atrial volume; LAVI, left atrial volume index; LVEDVI, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; LVESVI, left ventricular end-systolic volume index; RAAS, renin-angiotensin-aldosterone system; SV, stroke volume; SVI, stroke volume index; TAPSE, tricuspid annular plane systolic excursion.